ORKA - Oruka Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$149.56
DETAILS
HIGH:
$200.00
LOW:
$120.00
MEDIAN:
$151.00
CONSENSUS:
$149.56
UPSIDE:
61.63%
Institutional Holders (13F)
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-09-01 | Sandler Laura Lee | officer: Chief Operating Officer | M-Exempt | 5,000 | $7.80 | $39K |
| 2026-09-01 | Klein Lawrence Otto | director, officer: Chief Executive Officer | M-Exempt | 75,000 | $7.80 | $585K |
| 2026-09-01 | Klein Lawrence Otto | director, officer: Chief Executive Officer | SELL | 6,604 | $90.79 | $600K |
| 2026-09-01 | Klein Lawrence Otto | director, officer: Chief Executive Officer | SELL | 63,596 | $91.90 | $5.8M |
| 2026-09-01 | Klein Lawrence Otto | director, officer: Chief Executive Officer | SELL | 4,800 | $92.44 | $444K |
| 2026-09-01 | Sandler Laura Lee | officer: Chief Operating Officer | SELL | 1,000 | $91.05 | $91K |
| 2026-09-01 | Sandler Laura Lee | officer: Chief Operating Officer | SELL | 4,000 | $92.01 | $368K |
| 2026-08-24 | Edwards Larry Todd | officer | ? | -- | -- | -- |
| 2026-08-24 | Edwards Larry Todd | officer: Chief Commercial Officer | A-Award | 100,000 | -- | -- |
| 2026-08-24 | Edwards Larry Todd | officer: Chief Commercial Officer | A-Award | 20,000 | $102.42 | $2.0M |
| 2026-08-17 | Goncalves Joana | officer: Chief Medical Officer | SELL | 3,320 | $112.01 | $372K |
| 2026-08-17 | Goncalves Joana | officer: Chief Medical Officer | SELL | 2,480 | $112.56 | $279K |
| 2026-08-17 | Goncalves Joana | officer: Chief Medical Officer | SELL | 900 | $109.65 | $99K |
| 2026-08-17 | Goncalves Joana | officer: Chief Medical Officer | SELL | 300 | $110.52 | $33K |
| 2026-08-17 | Goncalves Joana | officer: Chief Medical Officer | M-Exempt | 3,500 | $6.84 | $24K |
| 2026-08-13 | Agarwal Arjun | officer: Senior Vice President, Finance | M-Exempt | 1,458 | $34.39 | $50K |
| 2026-08-13 | Agarwal Arjun | officer: Senior Vice President, Finance | M-Exempt | 8,542 | $12.50 | $107K |
| 2026-08-14 | Quinlan Paul T | officer: General Counsel | M-Exempt | 10,000 | $7.80 | $78K |
| 2026-08-14 | Quinlan Paul T | officer: General Counsel | M-Exempt | 42,000 | $12.50 | $525K |
| 2026-08-14 | Quinlan Paul T | officer: General Counsel | SELL | 3,630 | $106.05 | $385K |
| 2026-08-14 | Quinlan Paul T | officer: General Counsel | SELL | 10,434 | $107.14 | $1.1M |
| 2026-08-14 | Quinlan Paul T | officer: General Counsel | SELL | 14,696 | $107.97 | $1.6M |
| 2026-08-14 | Quinlan Paul T | officer: General Counsel | SELL | 10,200 | $109.11 | $1.1M |
| 2026-08-14 | Quinlan Paul T | officer: General Counsel | SELL | 9,193 | $110.00 | $1.0M |
| 2026-08-14 | Quinlan Paul T | officer: General Counsel | SELL | 3,847 | $111.14 | $428K |